{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:39:39Z","timestamp":1789580379874,"version":"build-2803163510"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Neurotrophic keratitis (NK) is a rare degenerative condition that is caused by damage to the trigeminal nerve, with partial or complete loss of corneal sensory innervation. The loss of innervation leads to impaired healing of corneal epithelium, which subsequently results in punctate epithelial erosions, persistent epithelial defects, corneal ulcers and corneal perforation. Management of NK is often supportive and aims to promote epithelial healing and prevent progression of disease. Multiple novel pharmacological approaches have been proposed to address the underlying pathophysiology of NK, which are discussed in this paper.<\/jats:p>","DOI":"10.3389\/fphar.2022.796854","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T16:15:45Z","timestamp":1648484145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Su Yin","family":"Koay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F. P.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4905487","DOI":"10.1155\/2018\/4905487","article-title":"Corneal Subbasal Nerve Recovery in an Acute Case of Ultraviolet Keratitis Treated with Autologous Serum Eye Drops","volume":"2018","author":"Abedi","year":"2018","journal-title":"J. Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jtos.2015.01.005","article-title":"Autologous Serum Tears for Treatment of Photoallodynia in Patients with Corneal Neuropathy: Efficacy and Evaluation with In Vivo Confocal Microscopy","volume":"13","author":"Aggarwal","year":"2015","journal-title":"Ocul. Surf."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1167\/iovs.12-10476","article-title":"Topical Treatment with a New Matrix Therapy Agent (RGTA) for the Treatment of Corneal Neurotrophic Ulcers","volume":"53","author":"Aifa","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.exer.2016.08.012","article-title":"PRGF Exerts More Potent Proliferative and Anti-inflammatory Effects Than Autologous Serum on a Cell Culture Inflammatory Model","volume":"151","author":"Anitua","year":"2016","journal-title":"Exp. Eye Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/ICO.0000000000000759","article-title":"Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers","volume":"35","author":"Arvola","year":"2016","journal-title":"Cornea"},{"key":"B6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/icl.0000000000000104","article-title":"Autologous Serum Eye Drops for the Treatment of Ocular Surface Disease","volume":"41","author":"Azari","year":"2015","journal-title":"Eye Contact Lens Sci. Clin. Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10719-016-9744-5","article-title":"RGTA\u00ae or ReGeneraTing Agents Mimic Heparan Sulfate in Regenerative Medicine: from Concept to Curing Patients","volume":"34","author":"Barritault","year":"2017","journal-title":"Glycoconj J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/jop.1994.10.683","article-title":"Insulin Administration to the Eyes of Normoglycemic Human Volunteers","volume":"10","author":"Bartlett","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/s0161-6420(00)00163-9","article-title":"Topical Treatment with Nerve Growth Factor for Neurotrophic Keratitis","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","article-title":"Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.eye.6700616","article-title":"Neurotrophic Keratitis","volume":"17","author":"Bonini","year":"2003","journal-title":"Eye (Lond)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/bjophthalmol-2018-313042","article-title":"Treatment of Neurotrophic Keratopathy with Minimally Invasive Corneal Neurotisation: Long-Term Clinical Outcomes and Evidence of Corneal Reinnervation","volume":"103","author":"Catapano","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/bjo.84.8.826","article-title":"Amniotic Membrane Transplantation for Severe Neurotrophic Corneal Ulcers","volume":"84","author":"Chen","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jfo.2018.05.009","article-title":"Healing of Resistant Corneal Neurotrophic Ulcers Using a Matrix Regenerating Agent","volume":"42","author":"Cochener","year":"2019","journal-title":"J. Fr Ophtalmol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40265-020-01289-w","article-title":"Cenegermin: A Review in Neurotrophic Keratitis","volume":"80","author":"Deeks","year":"2020","journal-title":"Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1177\/1120672120958307","article-title":"Topical Insulin for Refractory Persistent Corneal Epithelial Defects","volume":"31","author":"Diaz-Valle","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","article-title":"Neurotrophic Keratopathy","volume":"66","author":"Dua","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.2010.05471.x","article-title":"Treatment of Chronic Nonhealing Neurotrophic Corneal Epithelial Defects with Thymosin Beta4","volume":"1194","author":"Dunn","year":"2010","journal-title":"Ann. N. Y Acad. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.22608\/APO.201780","article-title":"Randomized Controlled Trial of Topical Insulin for Healing Corneal Epithelial Defects Induced during Vitreoretinal Surgery in Diabetics","volume":"6","author":"Fai","year":"2017","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ajo.2020.07.003","article-title":"Direct versus Indirect Corneal Neurotization for the Treatment of Neurotrophic Keratopathy: A Multicenter Prospective Comparative Study","volume":"220","author":"Fogagnolo","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial Effect of Artificial Tears Made with Autologous Serum in Patients with Keratoconjunctivitis Sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/ICO.0000000000001257","article-title":"Efficacy of 2-Month Treatment with Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study","volume":"36","author":"Giannaccare","year":"2017","journal-title":"Cornea"},{"key":"B23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clae.2012.07.009","article-title":"Scleral Contact Lens Management of Bilateral Exposure and Neurotrophic Keratopathy","volume":"35","author":"Grey","year":"2012","journal-title":"Cont Lens Anterior Eye"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1167\/iovs.11-8711","article-title":"Improved Corneal Wound Healing through Modulation of Gap Junction Communication Using Connexin43-specific Antisense Oligodeoxynucleotides","volume":"53","author":"Grupcheva","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1089\/jop.2017.0010","article-title":"Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent","volume":"33","author":"Guerra","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1136\/bjophthalmol-2020-316672","article-title":"Clinical and Confocal Imaging Findings in Congenital Corneal Anaesthesia","volume":"105","author":"Guillon-Rolf","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.sjopt.2014.06.011","article-title":"Management Strategies for Persistent Epithelial Defects of the Cornea","volume":"28","author":"Katzman","year":"2014","journal-title":"Saudi J. Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/01.ico.0000153102.19776.80","article-title":"Amniotic Membrane Transplantation in Refractory Neurotrophic Corneal Ulcers: a Randomized, Controlled Clinical Trial","volume":"24","author":"Khokhar","year":"2005","journal-title":"Cornea"},{"key":"B29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-012-0175-y","article-title":"Effect of Autologous Platelet-Rich Plasma on Persistent Corneal Epithelial Defect after Infectious Keratitis","volume":"56","author":"Kim","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0161-6420(88)33163-5","article-title":"Botulinum Toxin A-Induced Protective Ptosis in Corneal Disease","volume":"95","author":"Kirkness","year":"1988","journal-title":"Ophthalmology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00055735-199908000-00009","article-title":"Management of Neurotrophic Keratopathy","volume":"10","author":"Lambiase","year":"1999","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","article-title":"Topical Treatment with Nerve Growth Factor for Corneal Neurotrophic Ulcers","volume":"338","author":"Lambiase","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"521315","DOI":"10.1155\/2013\/521315","article-title":"Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery","volume":"2013","author":"Lekhanont","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajo.2020.04.036","article-title":"In\u00a0Vivo Evaluation of Corneal Nerves and Epithelial Healing after Treatment with Recombinant Nerve Growth Factor for Neurotrophic Keratopathy","volume":"217","author":"Mastropasqua","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/jcp.25623","article-title":"Understanding the Pathogenesis of Neurotrophic Keratitis: The Role of Corneal Nerves","volume":"232","author":"Mastropasqua","year":"2017","journal-title":"J. Cel Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous Serum Application in the Treatment of Neurotrophic Keratopathy","volume":"111","author":"Matsumoto","year":"2004","journal-title":"Ophthalmology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/tjo.tjo_5_20","article-title":"Amniotic Membrane Transplantation for Managing Dry Eye and Neurotrophic Keratitis","volume":"10","author":"Mead","year":"2020","journal-title":"Taiwan J. Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3238\/arztebl.2011.0243","article-title":"Amniotic Membrane Transplantation in the Human Eye","volume":"108","author":"Meller","year":"2011","journal-title":"Dtsch Arztebl Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","article-title":"Cytokine, Chemokine, and Growth Factor Profile of Platelet-Rich Plasma","volume":"27","author":"Mussano","year":"2016","journal-title":"Platelets"},{"key":"B40","volume-title":"Final Appraisal Determination \u2013 Cenegermin for Treating Neurotrophic Keratitis [Internet]","year":"2018"},{"key":"B41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s10384-007-0480-z","article-title":"Persistent Epithelial Defects Due to Neurotrophic Keratopathy Treated with a Substance P-Derived Peptide and Insulin-like Growth Factor 1","volume":"51","author":"Nishida","year":"2007","journal-title":"Jpn. J. Ophthalmol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.0.CO;2-8","article-title":"Synergistic Effects of Substance P with Insulin-like Growth Factor-1 on Epithelial Migration of the Cornea","volume":"169","author":"Nishida","year":"1996","journal-title":"J. Cel Physiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00232-012-9460-4","article-title":"Regulation of Connexin43 gap junction Protein Triggers Vascular Recovery and Healing in Human Ocular Persistent Epithelial Defect Wounds","volume":"245","author":"Ormonde","year":"2012","journal-title":"J. Membr. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","article-title":"Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial","volume":"127","author":"Pflugfelder","year":"2020","journal-title":"Ophthalmology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bjo.2009.164780","article-title":"Corneal Nerve Regeneration in Neurotrophic Keratopathy Following Autologous Plasma Therapy","volume":"94","author":"Rao","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10561-009-9128-1","article-title":"Serum Eye Drops, Amniotic Membrane and Limbal Epithelial Stem Cells-Ttools in the Treatment of Ocular Surface Disease","volume":"11","author":"Rauz","year":"2010","journal-title":"Cell Tissue Bank"},{"key":"B47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2147\/OPTH.S45921","article-title":"Diagnosis and Management of Neurotrophic Keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/ICL.0b013e31829fadde","article-title":"Episodes of Microbial Keratitis with Therapeutic Silicone Hydrogel Bandage Soft Contact Lenses","volume":"39","author":"Saini","year":"2013","journal-title":"Eye Contact Lens"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/archopht.124.10.1487","article-title":"Histopathology and Ultrastructure of Human Corneas after Amniotic Membrane Transplantation","volume":"124","author":"Seitz","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"B50","first-page":"1","article-title":"Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies","volume":"2014","author":"Semeraro","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000354380","article-title":"Neurotrophic Keratitis","volume":"231","author":"Semeraro","year":"2014","journal-title":"Ophthalmologica"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1167\/iovs.03-1064","article-title":"Insulin, Not Leptin, Promotes In Vitro Cell Migration to Heal Monolayer Wounds in Human Corneal Epithelium","volume":"45","author":"Shanley","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ophtha.2019.08.018","article-title":"Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology","volume":"127","author":"Shtein","year":"2020","journal-title":"Ophthalmology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3980\/j.issn.2222-3959.2014.06.12","article-title":"Curative Effect Assessment of Bandage Contact Lens in Neurogenic Keratitis","volume":"7","author":"Sun","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/PRS.0b013e3181904d3a","article-title":"Corneal Neurotization: a Novel Solution to Neurotrophic Keratopathy","volume":"123","author":"Terzis","year":"2009","journal-title":"Plast. Reconstr. Surg."},{"key":"B56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jtos.2020.11.003","article-title":"Assessment of Response to Multimodal Management of Neurotrophic Corneal Disease","volume":"19","author":"Trinh","year":"2021","journal-title":"Ocul. Surf."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","article-title":"Treatment of Persistent Corneal Epithelial Defect by Autologous Serum Application","volume":"106","author":"Tsubota","year":"1999","journal-title":"Ophthalmology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/bjo.87.11.1312","article-title":"Evaluation of Umbilical Cord Serum Therapy for Persistent Corneal Epithelial Defects","volume":"87","author":"Vajpayee","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/EB.S117261","article-title":"Neurotrophic Keratitis: Current Challenges and Future Prospects","volume":"10","author":"Versura","year":"2018","journal-title":"Eye Brain"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/ICO.0000000000001297","article-title":"Use of Topical Insulin to Treat Refractory Neurotrophic Corneal Ulcers","volume":"36","author":"Wang","year":"2017","journal-title":"Cornea"},{"key":"B61","doi-asserted-by":"crossref","first-page":"3538764","DOI":"10.1155\/2018\/3538764","article-title":"Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer","volume":"2018","author":"Wr\u00f3bel-Dudzi\u0144ska","year":"2018","journal-title":"J. Ophthalmol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/bjo.2007.130013","article-title":"Open Clinical Study of Eye-Drops Containing Tetrapeptides Derived from Substance P and Insulin-like Growth Factor-1 for Treatment of Persistent Corneal Epithelial Defects Associated with Neurotrophic Keratopathy","volume":"92","author":"Yamada","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1167\/iovs.05-1205","article-title":"Promotion of Corneal Epithelial Wound Healing by a Tetrapeptide (SSSR) Derived from IGF-1","volume":"47","author":"Yamada","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/01.ico.0000183484.85636.b6","article-title":"Application of Umbilical Cord Serum Eyedrops for the Treatment of Dry Eye Syndrome","volume":"25","author":"Yoon","year":"2006","journal-title":"Cornea"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","article-title":"Application of Umbilical Cord Serum Eyedrops for the Treatment of Neurotrophic Keratitis","volume":"114","author":"Yoon","year":"2007","journal-title":"Ophthalmology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.2147\/OPTH.S265701","article-title":"Human Platelets and Derived Products in Treating Ocular Surface Diseases - A Systematic Review","volume":"14","author":"You","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/archopht.125.8.1082","article-title":"Use of Topical Insulin to Normalize Corneal Epithelial Healing in Diabetes Mellitus","volume":"125","author":"Zagon","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ICL.0000000000000593","article-title":"Characteristics of Infectious Keratitis in Bandage Contact Lens Wear Patients","volume":"45","author":"Zhu","year":"2019","journal-title":"Eye Contact Lens"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.796854\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T16:15:57Z","timestamp":1648484157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.796854\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":68,"alternative-id":["10.3389\/fphar.2022.796854"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.796854","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"article-number":"796854"}}